Related Experiment Video
Updated: Jun 3, 2025

06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
8.6K
Pregnancy Complicated by Rapidly Progressing Vulvar Melanoma: A Case Study.
Bagas Satriyo Wicaksono1, Aditiyono Aditiyono2, Dina Marlina1
1Department of Obstetrics and Gynecology, Padjadjaran University, Bandung, West Java, Indonesia.
The American Journal of Case Reports
|January 10, 2025
Summary
Vulvar melanoma in pregnancy is rare and can progress aggressively due to hormonal changes. This case highlights a successful fetal outcome despite advanced maternal disease and a fatal maternal outcome.
Area of Science:
- Obstetrics and Gynecology
- Dermatology
- Oncology
Background:
- Vulvar melanoma during pregnancy is exceptionally rare.
- Pregnancy-associated hormonal and immunological shifts may influence melanoma behavior.
- Concerns exist regarding accelerated melanoma progression and maternal outcomes in pregnant patients.
Observation:
- A 40-year-old pregnant patient (28 weeks gestation) with a history of vulvar melanoma presented with abdominal pain and hematuria.
- Examination revealed a vulvar mass, cervical mass on ultrasonography, and elevated lactate dehydrogenase (LDH).
- The patient had received prior chemotherapy for vulvar malignant melanoma.
Findings:
- The patient underwent cesarean hysterectomy with colpotomy and bladder repair due to advanced metastatic vulvar melanoma involving the cervix and uterine corpus.
- Pregnancy was terminated at 27 weeks due to grade IV melanoma progression; the neonate was delivered in stable condition.
- The patient died one month post-operation.
Implications:
- This case underscores the potential for aggressive melanoma progression during pregnancy.
- Despite the aggressive nature of the disease, a favorable fetal outcome was achieved.
- The case illustrates the complex interplay between pregnancy and cancer progression, and the potential for conception after chemotherapy.
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
